Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingjun Bai

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Interventional Medicine|November 22, 2021
Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary resultsMingjun Bai, Tao Pan, Churen Zhou, et al.
ACS Applied Materials & Interfaces|July 19, 2017
Functionalized Selenium Nanosystem as Radiation Sensitizer of <sup>125</sup>I Seeds for Precise Cancer TherapyYahui Yang, Qiang Xie, Zhennan Zhao, et al.
European Journal of Pharmacology|March 19, 2019
Chiral ruthenium(II) complex Δ-[Ru(bpy)<sub>2</sub>(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2'-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damageMingjun Bai, Tao Pan, Gengnan Yu, et al.
European Radiology|January 22, 2016
Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort studyMingsheng Huang, Qu Lin, Haofan Wang, et al.
Journal of Hepatocellular Carcinoma|March 25, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP ScoreWenzhe Fan, Xinlin Zheng, Weihong Zhang, et al.
Journal of Cancer|January 2, 2018
Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer TherapiesXiurong Cai, Zhanhong Chen, Jie Chen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Interventional Medicine|November 22, 2021
Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary resultsMingjun Bai, Tao Pan, Churen Zhou, et al.
ACS Applied Materials & Interfaces|July 19, 2017
Functionalized Selenium Nanosystem as Radiation Sensitizer of <sup>125</sup>I Seeds for Precise Cancer TherapyYahui Yang, Qiang Xie, Zhennan Zhao, et al.
European Journal of Pharmacology|March 19, 2019
Chiral ruthenium(II) complex Δ-[Ru(bpy)<sub>2</sub>(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2'-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damageMingjun Bai, Tao Pan, Gengnan Yu, et al.
European Radiology|January 22, 2016
Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort studyMingsheng Huang, Qu Lin, Haofan Wang, et al.
Journal of Hepatocellular Carcinoma|March 25, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP ScoreWenzhe Fan, Xinlin Zheng, Weihong Zhang, et al.
Journal of Cancer|January 2, 2018
Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer TherapiesXiurong Cai, Zhanhong Chen, Jie Chen, et al.
Pageof 3